InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-13.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by BAKEWELL JOHN K, Director. Officer active across 4 companies, notably Neuronetics, Inc.. In total, 15 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €587k. History available since 15 August 2021. The latest transaction was filed on 20 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
23,917 shares0Common StockSEC:0000950170-25-075888:0
162,162 shares0Common StockSEC:0001235802-24-000067:0
15,091 shares0Common StockSEC:0000950170-24-063617:0
130,000 shares@ US$4.574100.0% of flowCommon StockSEC:0000950170-24-058974:0
Ideal exit: 4 Feb 2025 (T+270)
145,180 shares0Common StockSEC:0001235802-23-000090:0
14,400 shares@ US$2.70100.0% of flowCommon StockSEC:0001062993-23-012301:0
2,753 shares0Common StockSEC:0001209191-23-032354:0
215,415 shares0Common Stock, $0.000001 par valueSEC:0001235802-22-000097:0
38,910 sharesCommon StockSEC:0001062993-22-013871:0
2,295 shares0Common StockSEC:0001567619-22-011340:0
85,337 shares0Common Stock, $0.000001 par valueSEC:0001235802-21-000107
85,337 shares0Common Stock, $0.000001 par valueSEC:0001235802-21-000107:0
7,137 sharesCommon StockSEC:0001062993-21-005247
7,137 sharesCommon StockSEC:0001062993-21-005247:0
83,500 sharesCommon StockSEC:0000899243-16-010652:0
15 of 15 declarations
About BAKEWELL JOHN K
John K. Bakewell is a Board Member at Neuronetics, Inc., Xtant Medical Holdings, Inc., and Treace Medical Concepts, Inc. He contributes to the strategic direction of these companies, bringing his expertise in management and finance. His role on the board allows him to participate in important decision-making for the development and sustainability of these companies, ensuring they meet their financial objectives.
